Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 5/2012

Open Access 01-05-2012 | Editorial

PET/MRI in infectious and inflammatory diseases: will it be a useful improvement?

Authors: Andor W. J. M. Glaudemans, Ana Maria Quintero, Alberto Signore

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 5/2012

Login to get access

Excerpt

The knowledge of disease mechanisms and the identification of markers of disease development and progression, and for therapy evaluation, are rapidly expanding. Early diagnosis, possible disease prevention and individual therapy stratification are important goals in health care. Nuclear medicine and radiology are potentially able to satisfy these increasing demands for diagnosis, prevention, pathophysiological understanding and treatment possibilities. An increasing number of biomarkers, drugs, antibodies and peptides, contrast agents and MRI sequences have also been developed for these purposes. Together with this continuing search for the “holy grail” radiopharmaceutical, the use of hybrid imaging is another important development in the field. A recent development in hybrid cameras is the introduction of combined PET and MRI. Despite the intriguing novelty, it is important to evaluate carefully, in a cost–benefit manner, the possible advantages and clinical applications of such an expensive tool. …
Literature
1.
go back to reference Achenbach P, Bonifacio E, Koczwara K, Ziegler AG. Natural history of type 1 diabetes. Diabetes. 2005;54 Suppl 2:S25–31.PubMedCrossRef Achenbach P, Bonifacio E, Koczwara K, Ziegler AG. Natural history of type 1 diabetes. Diabetes. 2005;54 Suppl 2:S25–31.PubMedCrossRef
2.
go back to reference Nichols MT, Russ PD, Chen YK. Pancreatic imaging: current and emerging technologies. Pancreas. 2006;33:211–20.PubMedCrossRef Nichols MT, Russ PD, Chen YK. Pancreatic imaging: current and emerging technologies. Pancreas. 2006;33:211–20.PubMedCrossRef
3.
go back to reference Gaglia JL, Guimaraes AR, Harisinghani M, Turvey SE, Jackson R, Benoist C, et al. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest. 2011;121:442–5.PubMedCrossRef Gaglia JL, Guimaraes AR, Harisinghani M, Turvey SE, Jackson R, Benoist C, et al. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest. 2011;121:442–5.PubMedCrossRef
4.
go back to reference Barone R, Procaccini E, Chianelli M, Annovazzi A, Fiore V, Hawa M, et al. Prognostic relevance of pancreatic uptake of technetium-99m labelled human polyclonal immunoglobulins in patients with type 1 diabetes. Eur J Nucl Med. 1998;25:503–8.PubMedCrossRef Barone R, Procaccini E, Chianelli M, Annovazzi A, Fiore V, Hawa M, et al. Prognostic relevance of pancreatic uptake of technetium-99m labelled human polyclonal immunoglobulins in patients with type 1 diabetes. Eur J Nucl Med. 1998;25:503–8.PubMedCrossRef
5.
go back to reference Kalliokoski T, Simell O, Haaparanta M, Viljanen T, Solin O, Knuuti J, et al. An autoradiographic study of [(18)F]FDG uptake to islets of Langerhans in NOD mouse. Diabetes Res Clin Pract. 2005;70:217–24.PubMedCrossRef Kalliokoski T, Simell O, Haaparanta M, Viljanen T, Solin O, Knuuti J, et al. An autoradiographic study of [(18)F]FDG uptake to islets of Langerhans in NOD mouse. Diabetes Res Clin Pract. 2005;70:217–24.PubMedCrossRef
6.
go back to reference Kalliokoski T, Nuutila P, Virtanen KA, Iozzo P, Bucci M, Svedström E, et al. Pancreatic glucose uptake in vivo in men with newly diagnosed type 1 diabetes. J Clin Endocrinol Metab. 2008;93:1909–14.PubMedCrossRef Kalliokoski T, Nuutila P, Virtanen KA, Iozzo P, Bucci M, Svedström E, et al. Pancreatic glucose uptake in vivo in men with newly diagnosed type 1 diabetes. J Clin Endocrinol Metab. 2008;93:1909–14.PubMedCrossRef
7.
go back to reference Ladriere L, Malaisse-Lagae F, Alejandro R, Malaisse WJ. Pancreatic fate of a (125)I-labelled mouse monoclonal antibody directed against pancreatic B-cell surface ganglioside(s) in control and diabetic rats. Cell Biochem Funct. 2001;19:107–15.PubMedCrossRef Ladriere L, Malaisse-Lagae F, Alejandro R, Malaisse WJ. Pancreatic fate of a (125)I-labelled mouse monoclonal antibody directed against pancreatic B-cell surface ganglioside(s) in control and diabetic rats. Cell Biochem Funct. 2001;19:107–15.PubMedCrossRef
8.
go back to reference Malaisse WJ, Damhaut P, Malaisse-Lagae F, Ladriere L, Olivares E, Goldman S. Fate of 2-deoxy-2-[18F]fluoro-D-glucose in control and diabetic rats. Int J Mol Med. 2000;5:525–32.PubMed Malaisse WJ, Damhaut P, Malaisse-Lagae F, Ladriere L, Olivares E, Goldman S. Fate of 2-deoxy-2-[18F]fluoro-D-glucose in control and diabetic rats. Int J Mol Med. 2000;5:525–32.PubMed
9.
go back to reference Signore A, Chianelli M, Parisella MG, Capriotti G, Giacalone P, Di LG, et al. In vivo imaging of insulitis in autoimmune diabetes. J Endocrinol Invest. 1999;22:151–8.PubMed Signore A, Chianelli M, Parisella MG, Capriotti G, Giacalone P, Di LG, et al. In vivo imaging of insulitis in autoimmune diabetes. J Endocrinol Invest. 1999;22:151–8.PubMed
10.
go back to reference Chianelli M, Parisella MG, Visalli N, Mather SJ, D’Alessandria C, Pozzilli P, et al. Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy. Diabetes Metab Res Rev. 2008;24:115–22.PubMedCrossRef Chianelli M, Parisella MG, Visalli N, Mather SJ, D’Alessandria C, Pozzilli P, et al. Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy. Diabetes Metab Res Rev. 2008;24:115–22.PubMedCrossRef
11.
go back to reference Signore A, Chianelli M, Ronga G, Pozzilli P, Beverley PC. In vivo labelling of activated T lymphocytes by i.v. injection of 123I-IL2 for detection of insulitis in type 1 diabetes. Prog Clin Biol Res. 1990;355:229–38.PubMed Signore A, Chianelli M, Ronga G, Pozzilli P, Beverley PC. In vivo labelling of activated T lymphocytes by i.v. injection of 123I-IL2 for detection of insulitis in type 1 diabetes. Prog Clin Biol Res. 1990;355:229–38.PubMed
12.
go back to reference Signore A, Chianelli M, Ferretti E, Toscano A, Britton KE, Andreani D, et al. New approach for in vivo detection of insulitis in type I diabetes: activated lymphocyte targeting with 123I-labelled interleukin 2. Eur J Endocrinol. 1994;131:431–7.PubMedCrossRef Signore A, Chianelli M, Ferretti E, Toscano A, Britton KE, Andreani D, et al. New approach for in vivo detection of insulitis in type I diabetes: activated lymphocyte targeting with 123I-labelled interleukin 2. Eur J Endocrinol. 1994;131:431–7.PubMedCrossRef
13.
go back to reference Sobottke R, Rollinghoff M, Zarghooni K, Zarghooni K, Schluter-Brust K, Delank KS, et al. Spondylodiscitis in the elderly patient: clinical mid-term results and quality of life. Arch Orthop Trauma Surg. 2010;130:1083–91.PubMedCrossRef Sobottke R, Rollinghoff M, Zarghooni K, Zarghooni K, Schluter-Brust K, Delank KS, et al. Spondylodiscitis in the elderly patient: clinical mid-term results and quality of life. Arch Orthop Trauma Surg. 2010;130:1083–91.PubMedCrossRef
14.
go back to reference Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother. 2010;65 Suppl 3:iii11–24.PubMedCrossRef Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother. 2010;65 Suppl 3:iii11–24.PubMedCrossRef
15.
go back to reference Verstraete KL, Huysse WC. Health technology assessment of magnetic resonance imaging of the spine and bone marrow. Eur J Radiol. 2008;65:201–10.PubMedCrossRef Verstraete KL, Huysse WC. Health technology assessment of magnetic resonance imaging of the spine and bone marrow. Eur J Radiol. 2008;65:201–10.PubMedCrossRef
16.
go back to reference Loftus Jr EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–17.PubMedCrossRef Loftus Jr EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–17.PubMedCrossRef
17.
go back to reference Maccioni F, Bruni A, Viscido A, Colaiacomo MC, Cocco A, Montesani C, et al. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology. 2006;238:517–30.PubMedCrossRef Maccioni F, Bruni A, Viscido A, Colaiacomo MC, Cocco A, Montesani C, et al. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology. 2006;238:517–30.PubMedCrossRef
18.
go back to reference Glaudemans AW, Maccioni F, Mansi L, Dierckx RA, Signore A. Imaging of cell trafficking in Crohn’s disease. J Cell Physiol. 2010;223:562–71.PubMed Glaudemans AW, Maccioni F, Mansi L, Dierckx RA, Signore A. Imaging of cell trafficking in Crohn’s disease. J Cell Physiol. 2010;223:562–71.PubMed
19.
go back to reference Rimola J, Rodriguez S, Garcia-Bosch O, Ordas I, Ayala E, Aceituno M, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut. 2009;58:1113–20.PubMedCrossRef Rimola J, Rodriguez S, Garcia-Bosch O, Ordas I, Ayala E, Aceituno M, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut. 2009;58:1113–20.PubMedCrossRef
20.
21.
go back to reference Kiryu S, Dodanuki K, Takao H, Watanabe M, Inoue Y, Takazoe M, et al. Free-breathing diffusion-weighted imaging for the assessment of inflammatory activity in Crohn’s disease. J Magn Reson Imaging. 2009;29:880–6.PubMedCrossRef Kiryu S, Dodanuki K, Takao H, Watanabe M, Inoue Y, Takazoe M, et al. Free-breathing diffusion-weighted imaging for the assessment of inflammatory activity in Crohn’s disease. J Magn Reson Imaging. 2009;29:880–6.PubMedCrossRef
22.
23.
go back to reference Capriotti G, Chianelli M, Signore A. Nuclear medicine imaging of diabetic foot infection: results of meta-analysis. Nucl Med Commun. 2006;27:757–64.PubMedCrossRef Capriotti G, Chianelli M, Signore A. Nuclear medicine imaging of diabetic foot infection: results of meta-analysis. Nucl Med Commun. 2006;27:757–64.PubMedCrossRef
24.
go back to reference de Vries EF, Roca M, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37:842–8.PubMedCrossRef de Vries EF, Roca M, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37:842–8.PubMedCrossRef
25.
go back to reference Roca M, de Vries EF, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with (111)In-oxine. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37:835–41.PubMedCrossRef Roca M, de Vries EF, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with (111)In-oxine. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37:835–41.PubMedCrossRef
26.
go back to reference Familiari D, Glaudemans AW, Vitale V, Prosperi D, Bagni O, Lenza A, et al. Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot? J Nucl Med. 2011;52:1012–9.PubMedCrossRef Familiari D, Glaudemans AW, Vitale V, Prosperi D, Bagni O, Lenza A, et al. Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot? J Nucl Med. 2011;52:1012–9.PubMedCrossRef
Metadata
Title
PET/MRI in infectious and inflammatory diseases: will it be a useful improvement?
Authors
Andor W. J. M. Glaudemans
Ana Maria Quintero
Alberto Signore
Publication date
01-05-2012
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 5/2012
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-012-2060-9

Other articles of this Issue 5/2012

European Journal of Nuclear Medicine and Molecular Imaging 5/2012 Go to the issue